IB-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IB-001, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B [Phase 1]